SNDL (SNDL) shares gained nearly 12% on Wednesday. Dec. 16 following reports that President Donald Trump could reclassify cannabis as a “Schedule III” drug by the end of this week. The U.S. government is considering a policy shift that would offer some seniors access to cannabis products under Medicare coverage as well, the reports added. More News from Barchart SNDL stock has been a volatile investment this year. Despite a sharp rally on Tuesday, it’s down more than 25% versus its year-to-date high in ...

Group 1 - The cannabis sector has been gaining momentum since August due to a positive policy shift towards cannabis, supported by President Trump's comments on rescheduling and promoting medical cannabis [1] - The article emphasizes the importance of thorough research and analysis of financial statements, market trends, and upcoming events that may impact specific companies or industries [1]